Serological response following BNT162b2 anti‐SARS‐CoV‐2 mRNA vaccination in haematopoietic stem cell transplantation patients

Saved in:

Bibliographic Details
Published in	British journal of haematology Vol. 196; no. 4; pp. 928 - 931
Main Authors	Attolico, Immacolata, Tarantini, Francesco, Carluccio, Paola, Schifone, Claudia Pia, Delia, Mario, Gagliardi, Vito Pier, Perrone, Tommasina, Gaudio, Francesco, Longo, Chiara, Giordano, Annamaria, Sgherza, Nicola, Curci, Paola, Rizzi, Rita, Ricco, Alessandra, Russo Rossi, Antonella, Albano, Francesco, Larocca, Angela Maria Vittoria, Vimercati, Luigi, Tafuri, Silvio, Musto, Pellegrino
Format	Journal Article
Language	English
Published	England Blackwell Publishing Ltd 01.02.2022 John Wiley and Sons Inc
Subjects	Adult Aged Antibodies, Viral - blood Antibodies, Viral - immunology BNT162 Vaccine - pharmacology BNT162 Vaccine - therapeutic use Correspondence Correspondence‐COVID‐19 COVID-19 - blood COVID-19 - immunology COVID-19 - prevention & control Female Hematology Hematopoietic Stem Cell Transplantation Hematopoietic stem cells Humans Immunogenicity, Vaccine Immunoglobulin G - blood Immunoglobulin G - immunology Male Middle Aged mRNA SARS-CoV-2 - immunology Seroconversion Severe acute respiratory syndrome coronavirus 2 severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) vaccination Stem cell transplantation Vaccination Young Adult seroconversion stem cell transplantation severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccination
Online Access	Get full text
ISSN	0007-1048 1365-2141 1365-2141
DOI	10.1111/bjh.17873

More Information
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Correspondence-1
ISSN:	0007-1048 1365-2141 1365-2141
DOI:	10.1111/bjh.17873